Website intended for a NZ health professional readership
Representatives from some of the biggest companies in Australasia’s health technology sector were on hand for this week’s Medical Technology Association of NZ (MTANZ) Conference in Auckland.
The two day-event which started on Monday included a range of speakers, from associate minister of health David Seymour and new Pharmac chair Paula Bennett to the Australian productivity commissioner Catherine de Fontenay. Key topics up for discussion included the Government’s plan to transfer responsibility for funding medical devices from Te Whatu Ora to Pharmac and the proposed repeal of the Therapeutic Products Act.
When co-prescribing serotonergic medications, it is important to be able to assess the risk of clinically significant interactions – to prevent serotonin toxicity but also to avoid unnecessary restriction of therapeutic options. In this article, Pauline McQuoid looks at the likelihood of serotonin toxicity when the computerised drug interaction alert says ‘no’